TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
暂无分享,去创建一个
R. Petersen | B. Boeve | M. Senjem | D. Knopman | S. Weigand | M. Murray | D. Dickson | J. Parisi | J. Whitwell | K. Josephs | M. Machulda | N. Tosakulwong | Alexandre Bejanin | Aradhana Sahoo | A. Serie
[1] C. Jack,et al. Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study , 2017, The Lancet Neurology.
[2] Charles D. Smith,et al. “New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS) , 2016, Journal of neuropathology and experimental neurology.
[3] Jennifer L. Whitwell,et al. Updated TDP-43 in Alzheimer’s disease staging scheme , 2016, Acta Neuropathologica.
[4] L. Petrucelli,et al. TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features , 2015, Annals of neurology.
[5] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[6] C. Jack,et al. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.
[7] C. Jack,et al. Staging TDP-43 pathology in Alzheimer’s disease , 2014, Acta Neuropathologica.
[8] D. Bennett,et al. TDP-43 pathology, cognitive decline, and dementia in old age. , 2013, JAMA neurology.
[9] C. Jack,et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.
[10] Jason D. Warren,et al. Alzheimer's pathology in primary progressive aphasia , 2012, Neurobiology of Aging.
[11] Nick C Fox,et al. Posterior cortical atrophy , 2012, The Lancet Neurology.
[12] H. Akiyama. [CERAD (The Consortium to Establish a Registry for Alzheimer's Disease) criteria]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[13] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[14] D. Dickson,et al. TDP-43 in aging and Alzheimer's disease - a review. , 2011, International journal of clinical and experimental pathology.
[15] Nancy Johnson,et al. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease , 2010, Acta Neuropathologica.
[16] Sébastien Ourselin,et al. Progressive logopenic/phonological aphasia: Erosion of the language network , 2010, NeuroImage.
[17] B. Miller,et al. The logopenic/phonological variant of primary progressive aphasia , 2008, Neurology.
[18] C. Jack,et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype , 2008, Neurology.
[19] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[20] Gerald van Belle,et al. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years , 2008, Alzheimer's & Dementia.
[21] J. Morris,et al. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. , 2007, Archives of neurology.
[22] D Harrich,et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs , 1995, Journal of virology.
[23] M. Mendez,et al. Pick's disease versus Alzheimer's disease , 1993, Neurology.